Skip to content
10-K

Annual Report

CEREVEL THERAPEUTICS HOLDINGS, INC.

0000950170-23-003777

← back to feed
Filed
Feb 22, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Long Term Debt FY 2022 · Dec 31, 2022 $388.1M
Revenue FY 2022 · Dec 31, 2022 $0
Cash And Equivalents FY 2022 · Dec 31, 2021 $193.02M
Current Liabilities FY 2022 · Dec 31, 2021 $42.54M
Total Liabilities FY 2022 · Dec 31, 2021 $110.19M
Current Assets FY 2022 · Dec 31, 2021 $578.02M
Total Assets FY 2022 · Dec 31, 2021 $688.92M
Shares Diluted FY 2022 · Dec 31, 2020 73.64M sh
Capex FY 2022 · Dec 31, 2020 $18.89M
Operating Cash Flow FY 2022 · Dec 31, 2020 −$117.8M
Eps Diluted FY 2022 · Dec 31, 2020 −$2.01
Eps Basic FY 2022 · Dec 31, 2020 −$2.01
Sga Expense FY 2022 · Dec 31, 2020 $45.81M
Rd Expense FY 2022 · Dec 31, 2020 $103.3M
Net Income FY 2022 · Dec 31, 2020 −$152.14M
Operating Income FY 2022 · Dec 31, 2020 −$149.12M
Stockholders Equity FY 2022 · Dec 31, 2019 $77.82M